Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): Indication: For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment)
TB-500 (Thymosin Beta-4 Acetate) is a synthetic 43-amino acid peptide derived from thymosin beta-4, a protein found in high concentrations in platelets, white blood cells, and wound fluid
and (3) studies in which at least one group was treated with any dose of tirzepatide
For practitioners treating GLP-1 agonist non-responders, understanding these biological adaptations proves essential, as they explain why willpower alone rarely suffices for sustainable results
2 Within the gastrointestinal (GI) tract, activation of GLP-1R reduces gastric muscle contractions and slows gastric emptying, prolonging satiety and reducing post-prandial glucose spikes